Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
17. März 2020 07:30 ET
|
Abeona Therapeutics Inc.
Majority of potential study participants have been pre-screened EB-101 successfully manufactured at Abeona and transplanted at Stanford University Medical Center NEW YORK and CLEVELAND, March 17,...
Abeona Therapeutics leitet klinische Phase-3-Schlüsselstudie zur Beurteilung der Gentherapie EB-101 bei rezessiver dystropher Epidermolysis bullosa (RDEB) ein
13. Januar 2020 15:32 ET
|
Abeona Therapeutics Inc.
Die Studie ist für die Rekrutierung geöffnet und das Patientenscreening ist an der Stanford University angelaufen Das Unternehmen erwartet die Behandlung des ersten Patienten im ersten Quartal 2020 ...
Abeona Therapeutics lance un essai clinique pivot de phase 3 évaluant la thérapie génique EB-101 pour l'épidermolyse bulleuse dystrophique récessive
13. Januar 2020 15:32 ET
|
Abeona Therapeutics Inc.
Les inscriptions à l'étude sont ouvertes et la sélection des patients est en cours à l'Université de Stanford La société s'attend à ce qu'un premier patient soit traité au cours du premier trimestre...
Abeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
13. Januar 2020 09:00 ET
|
Abeona Therapeutics Inc.
Study open for enrollment and patient screening underway at Stanford University Company expects first patient to be treated in the first quarter of 2020 EB-101 manufactured at Abeona facility in...
DEADLINE FRIDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Eventbrite, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
12. Juni 2019 12:28 ET
|
Schall Law
LOS ANGELES, June 12, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eventbrite, Inc....
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Eventbrite, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
03. Juni 2019 12:15 ET
|
Schall Law
LOS ANGELES, June 03, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eventbrite, Inc....
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Eventbrite, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
27. Mai 2019 11:40 ET
|
Schall Law
LOS ANGELES, May 27, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eventbrite, Inc....
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Eventbrite, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
20. Mai 2019 12:15 ET
|
Schall Law
LOS ANGELES, May 20, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eventbrite, Inc....
EB ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Eventbrite, Inc. – EB
15. Mai 2019 15:54 ET
|
Zhang Investor Law P.C.
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Eventbrite, Inc. (NYSE: EB) from September...
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Eventbrite, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
13. Mai 2019 16:30 ET
|
Schall Law
LOS ANGELES, May 13, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Eventbrite, Inc....